James Li, JW Therapeutics CEO
Sister to Juno's liso-cel, JW's relma-cel lands second-ever CAR-T approval in China
Juno may have stumbled its way to a distant third finish in the CD19 CAR-T race, but its joint venture in China is heading off …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
